436 related articles for article (PubMed ID: 33089580)
1. Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration.
Briel N; Pratsch K; Roeber S; Arzberger T; Herms J
Brain Pathol; 2021 Jul; 31(4):e12914. PubMed ID: 33089580
[TBL] [Abstract][Full Text] [Related]
2. Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration.
Yoshida M
Neuropathology; 2014 Dec; 34(6):555-70. PubMed ID: 25124031
[TBL] [Abstract][Full Text] [Related]
3. Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration.
Koga S; Metrick MA; Golbe LI; Santambrogio A; Kim M; Soto-Beasley AI; Walton RL; Baker MC; De Castro CF; DeTure M; Russell D; Navia BA; Sandiego C; Ross OA; Vendruscolo M; Caughey B; Dickson DW
Acta Neuropathol Commun; 2023 Jun; 11(1):88. PubMed ID: 37264457
[TBL] [Abstract][Full Text] [Related]
4. Single-nucleus chromatin accessibility profiling highlights distinct astrocyte signatures in progressive supranuclear palsy and corticobasal degeneration.
Briel N; Ruf VC; Pratsch K; Roeber S; Widmann J; Mielke J; Dorostkar MM; Windl O; Arzberger T; Herms J; Struebing FL
Acta Neuropathol; 2022 Oct; 144(4):615-635. PubMed ID: 35976433
[TBL] [Abstract][Full Text] [Related]
5. Machine learning-based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration.
Koga S; Zhou X; Dickson DW
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):931-941. PubMed ID: 33763863
[TBL] [Abstract][Full Text] [Related]
6. Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain.
Hattori M; Hashizume Y; Yoshida M; Iwasaki Y; Hishikawa N; Ueda R; Ojika K
Acta Neuropathol; 2003 Aug; 106(2):143-9. PubMed ID: 12732936
[TBL] [Abstract][Full Text] [Related]
7. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity.
Fu YJ; Nishihira Y; Kuroda S; Toyoshima Y; Ishihara T; Shinozaki M; Miyashita A; Piao YS; Tan CF; Tani T; Koike R; Iwanaga K; Tsujihata M; Onodera O; Kuwano R; Nishizawa M; Kakita A; Ikeuchi T; Takahashi H
Acta Neuropathol; 2010 Jul; 120(1):21-32. PubMed ID: 20140439
[TBL] [Abstract][Full Text] [Related]
8. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).
Dickson DW; Kouri N; Murray ME; Josephs KA
J Mol Neurosci; 2011 Nov; 45(3):384-9. PubMed ID: 21720721
[TBL] [Abstract][Full Text] [Related]
9. A Case of Pathologically Confirmed Corticobasal Degeneration Initially Presenting as Progressive Supranuclear Palsy Syndrome.
Chung EJ; Cho HJ; Jang W; Hur DY; Kim YS; Lee KH; Kim SJ
J Korean Med Sci; 2022 Jun; 37(22):e183. PubMed ID: 35668689
[TBL] [Abstract][Full Text] [Related]
10. Chameleons and mimics: Progressive supranuclear palsy and corticobasal degeneration.
Mimuro M; Yoshida M
Neuropathology; 2020 Feb; 40(1):57-67. PubMed ID: 31515852
[TBL] [Abstract][Full Text] [Related]
11. A proteomic study identifies different levels of light chain ferritin in corticobasal degeneration and progressive supranuclear palsy.
Ebrahim AS; Kulathingal J; Murray ME; Casey-Castanedes M; Dickson DW; Yen SH; Sevlever D
Acta Neuropathol; 2011 Dec; 122(6):727-36. PubMed ID: 22012136
[TBL] [Abstract][Full Text] [Related]
12. Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.
Ando K; Tomimura K; Sazdovitch V; Suain V; Yilmaz Z; Authelet M; Ndjim M; Vergara C; Belkouch M; Potier MC; Duyckaerts C; Brion JP
Neurobiol Dis; 2016 Oct; 94():32-43. PubMed ID: 27260836
[TBL] [Abstract][Full Text] [Related]
13. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
Katsuse O; Iseki E; Arai T; Akiyama H; Togo T; Uchikado H; Kato M; de Silva R; Lees A; Kosaka K
Acta Neuropathol; 2003 Sep; 106(3):251-60. PubMed ID: 12802605
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
[TBL] [Abstract][Full Text] [Related]
15. Tau immunotherapy is associated with glial responses in FTLD-tau.
Kim B; Mikytuck B; Suh E; Gibbons GS; Van Deerlin VM; Vaishnavi SN; Spindler MA; Massimo L; Grossman M; Trojanowski JQ; Irwin DJ; Lee EB
Acta Neuropathol; 2021 Aug; 142(2):243-257. PubMed ID: 33950293
[TBL] [Abstract][Full Text] [Related]
16. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.
Dickson DW
J Neurol; 1999 Sep; 246 Suppl 2():II6-15. PubMed ID: 10525997
[TBL] [Abstract][Full Text] [Related]
17. Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures.
Valentino RR; Tamvaka N; Heckman MG; Johnson PW; Soto-Beasley AI; Walton RL; Koga S; Uitti RJ; Wszolek ZK; Dickson DW; Ross OA
Acta Neuropathol Commun; 2020 Sep; 8(1):162. PubMed ID: 32943110
[TBL] [Abstract][Full Text] [Related]
18. Relationship Between
Josephs KA; Tosakulwong N; Weigand SD; Buciuc M; Lowe VJ; Dickson DW; Whitwell JL
J Nucl Med; 2022 Jun; 63(6):931-935. PubMed ID: 34556525
[TBL] [Abstract][Full Text] [Related]
19. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
[TBL] [Abstract][Full Text] [Related]
20. Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy.
Komori T; Arai N; Oda M; Nakayama H; Mori H; Yagishita S; Takahashi T; Amano N; Murayama S; Murakami S; Shibata N; Kobayashi M; Sasaki S; Iwata M
Acta Neuropathol; 1998 Oct; 96(4):401-8. PubMed ID: 9797005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
